ATE389417T1 - METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY BOWEL DISEASE - Google Patents
METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY BOWEL DISEASEInfo
- Publication number
- ATE389417T1 ATE389417T1 AT98912149T AT98912149T ATE389417T1 AT E389417 T1 ATE389417 T1 AT E389417T1 AT 98912149 T AT98912149 T AT 98912149T AT 98912149 T AT98912149 T AT 98912149T AT E389417 T1 ATE389417 T1 AT E389417T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- methods
- inflammatory bowel
- bowel disease
- treating inflammatory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO5940A AUPO594097A0 (en) | 1997-04-01 | 1997-04-01 | Novel methods of treating inflammatory bowel disease |
AUPO9785A AUPO978597A0 (en) | 1997-10-14 | 1997-10-14 | Methods of treating inflammatory bowel disease |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE389417T1 true ATE389417T1 (en) | 2008-04-15 |
Family
ID=25645389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98912149T ATE389417T1 (en) | 1997-04-01 | 1998-04-01 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY BOWEL DISEASE |
Country Status (16)
Country | Link |
---|---|
US (1) | US6277836B1 (en) |
EP (1) | EP0971735B1 (en) |
JP (3) | JP2001524951A (en) |
AR (1) | AR012304A1 (en) |
AT (1) | ATE389417T1 (en) |
CA (1) | CA2285923C (en) |
CY (1) | CY1109783T1 (en) |
DE (1) | DE69839261T2 (en) |
DK (1) | DK0971735T3 (en) |
ES (1) | ES2303351T3 (en) |
IL (1) | IL132145A (en) |
NO (1) | NO325947B1 (en) |
NZ (1) | NZ500696A (en) |
PT (1) | PT971735E (en) |
SI (1) | SI0971735T1 (en) |
WO (1) | WO1998043667A1 (en) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6551632B2 (en) * | 1997-04-01 | 2003-04-22 | Thomas Julius Borody | Methods and compositions for treating inflammatory bowel disease |
AUPP325398A0 (en) * | 1998-04-30 | 1998-05-21 | Borody, Thomas J. | Improved method for eradicating h. pylori |
AU764681C (en) * | 1999-02-12 | 2005-07-07 | Washington University | Stimulating neutrophil function to treat inflammatory bowel disease |
EP1226138B1 (en) * | 1999-10-08 | 2004-12-29 | Affinium Pharmaceuticals, Inc. | Fab i inhibitors |
JP3369535B2 (en) | 1999-11-09 | 2003-01-20 | 松下電器産業株式会社 | Plasma display device |
US7638496B2 (en) | 2000-02-15 | 2009-12-29 | Valeant Pharmaceuticals North America | Nucleoside analogs with carboxamidine modified monocyclic base |
AU2001263812B2 (en) * | 2000-03-28 | 2004-09-23 | Sandoz Ag | Granulated particles with masked taste |
ATE448194T1 (en) * | 2000-08-29 | 2009-11-15 | Biocon Ltd | USE OF A PHARMACEUTICAL COMPOSITION CONTAINING A PARA-AMINOPHENYLACETIC ACID DERIVATIVE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT |
WO2003088897A2 (en) * | 2001-04-06 | 2003-10-30 | Affinium Pharmaceuticals, Inc. | Fab i inhibitors |
US8048924B2 (en) | 2001-08-29 | 2011-11-01 | Biocon Limited | Methods and compositions employing 4-aminophenylacetic acid compounds |
US20030118329A1 (en) * | 2001-12-21 | 2003-06-26 | Pere Obrador | Video indexing using high resolution still images |
AUPS088702A0 (en) | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
EP1575951B1 (en) | 2002-12-06 | 2014-06-25 | Debiopharm International SA | Heterocyclic compounds, methods of making them and their use in therapy |
CA2519429C (en) | 2003-03-17 | 2013-08-06 | Affinium Pharmaceuticals, Inc. | Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics |
US6930093B2 (en) * | 2003-07-10 | 2005-08-16 | Valeant Research & Development | Use of ribofuranose derivatives against inflammatory bowel diseases |
WO2005046567A2 (en) * | 2003-09-10 | 2005-05-26 | Meena Shelgaonkar | Synergistic formulation of antioxidants and antimycobacterial agents: a method of making the same |
US7417037B2 (en) * | 2004-01-20 | 2008-08-26 | The Board Of Regents Of The University Of Oklahoma | Compositions and methods of treatment for inflammatory diseases |
EP2361620B1 (en) | 2004-02-06 | 2016-04-06 | PHARMATEL (R&D) PTY LIMITED as Trustee for the PHARMATEL (R & D) TRUST | Use of aminosalicylates in diarrhoea-predominant irritable bowel syndrome |
JP5009152B2 (en) * | 2004-05-28 | 2012-08-22 | サリックス ファーマシューティカルズ, インコーポレイテッド | Prevention, treatment, and recovery of radiation-induced enteritis |
PT1828167E (en) * | 2004-06-04 | 2014-10-08 | Debiopharm Int Sa | Acrylamide derivatives as antibiotic agents |
US7932366B2 (en) | 2004-07-07 | 2011-04-26 | Biocon Limited | Synthesis of azo bonded immunoregulatory compounds |
NZ565974A (en) * | 2005-08-24 | 2012-07-27 | Salix Pharmaceuticals Ltd | Balsalazide formulations and manufacture and use thereof |
US7452872B2 (en) * | 2005-08-24 | 2008-11-18 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
US8921344B2 (en) * | 2006-11-03 | 2014-12-30 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
EP1973902A2 (en) * | 2005-12-05 | 2008-10-01 | Affinium Pharmaceuticals, Inc. | 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
CA2531261A1 (en) * | 2005-12-21 | 2007-06-21 | Institut Pasteur | Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria |
JP5468899B2 (en) | 2006-07-20 | 2014-04-09 | アフィニウム ファーマシューティカルズ, インク. | Acrylamide derivatives as FABI inhibitors |
WO2008098374A1 (en) | 2007-02-16 | 2008-08-21 | Affinium Pharmaceuticals, Inc. | Salts, prodrugs and polymorphs of fab i inhibitors |
US8217083B2 (en) * | 2007-06-08 | 2012-07-10 | Aptalis Pharma Canada Inc. | Mesalamine suppository |
US7541384B2 (en) | 2007-06-08 | 2009-06-02 | Axcan Pharma Inc. | Mesalamine suppository |
US8436051B2 (en) | 2007-06-08 | 2013-05-07 | Aptalis Pharma Canada Inc. | Mesalamine suppository |
US20090098088A1 (en) * | 2007-10-10 | 2009-04-16 | The Procter & Gamble Company | Methods And Kits For The Treatment Of Diverticular Conditions |
WO2009047801A1 (en) * | 2007-10-10 | 2009-04-16 | Lupin Limited | Therapeutic combinations and compositions for the treatment of gastrointestinal disorders |
US20090131343A1 (en) * | 2007-11-15 | 2009-05-21 | Ly Tam Phan | Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases |
NZ587250A (en) * | 2008-02-08 | 2011-12-22 | Red Hill Biopharma Ltd | Methods and compositions for treating inflammatory bowel disease |
AU2009243066A1 (en) * | 2008-05-01 | 2009-11-05 | The Procter & Gamble Company | Methods and kits for the treatment of inflammatory bowel disorder conditions |
US20110082120A1 (en) * | 2009-10-05 | 2011-04-07 | Milne Jill C | Substituted thioacetic acid salicylate derivatives and their uses |
ES2762442T3 (en) | 2009-10-26 | 2020-05-25 | Borody Thomas J | Novel enteric combination therapy |
BR112012027520A2 (en) | 2010-04-26 | 2015-09-15 | Salix Pharmaceuticals Ltd | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males |
AU2011342368B2 (en) | 2010-12-13 | 2016-11-17 | Rite-Prep Pty Ltd | Gastric and colonic formulations and methods for making and using them |
TWI573590B (en) * | 2011-09-20 | 2017-03-11 | 雷希爾生藥有限公司 | A composition and method for treating an autoimmune disease |
BR112014031635B1 (en) | 2012-06-19 | 2022-01-11 | Debiopharm International Sa | PRO-Drug DERIVATIVES OF (E)-N-METHYL-N-((3-METHYLBENZOFURAN-2-YL) METHYL)-3-(7-OXO-5,6,7,8-TETRAHYDRO-1,8- NAFTIRINDIN-3-IL) ACRYLAMIDE |
DK2877163T3 (en) | 2012-07-27 | 2019-04-15 | Redhill Biopharma Ltd | FORMULATIONS AND PROCEDURES FOR THE PREPARATION OF FORMS FOR USING GAS DRAINAGE |
US20150335672A1 (en) | 2014-05-22 | 2015-11-26 | John Todd Kuenstner | Treatment of Diseases Using Combination of Ultraviolet Blood Irradiation and Antibiotics |
CN108778286A (en) | 2016-02-26 | 2018-11-09 | 德彪药业国际股份公司 | Drug for treating infection in diabetic foot |
EP4171546A4 (en) | 2020-06-30 | 2024-03-13 | Redhill Biopharma Ltd | Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4440763A (en) * | 1981-03-18 | 1984-04-03 | Block Drug Company, Inc. | Use of 4-aminosalicyclic acid as an anti-inflammatory agent |
GB8919321D0 (en) * | 1989-08-25 | 1989-10-11 | Univ London | Treatment of chronic inflammatory conditions |
-
1998
- 1998-04-01 AR ARP980101486A patent/AR012304A1/en unknown
- 1998-04-01 DK DK98912149T patent/DK0971735T3/en active
- 1998-04-01 ES ES98912149T patent/ES2303351T3/en not_active Expired - Lifetime
- 1998-04-01 NZ NZ500696A patent/NZ500696A/en not_active IP Right Cessation
- 1998-04-01 AT AT98912149T patent/ATE389417T1/en active
- 1998-04-01 DE DE69839261T patent/DE69839261T2/en not_active Expired - Lifetime
- 1998-04-01 WO PCT/AU1998/000222 patent/WO1998043667A1/en active IP Right Grant
- 1998-04-01 IL IL13214598A patent/IL132145A/en not_active IP Right Cessation
- 1998-04-01 SI SI9830905T patent/SI0971735T1/en unknown
- 1998-04-01 EP EP98912149A patent/EP0971735B1/en not_active Expired - Lifetime
- 1998-04-01 JP JP54099898A patent/JP2001524951A/en not_active Withdrawn
- 1998-04-01 CA CA2285923A patent/CA2285923C/en not_active Expired - Lifetime
- 1998-04-01 PT PT98912149T patent/PT971735E/en unknown
- 1998-04-01 US US09/381,960 patent/US6277836B1/en not_active Expired - Lifetime
-
1999
- 1999-09-30 NO NO19994778A patent/NO325947B1/en not_active IP Right Cessation
-
2007
- 2007-09-07 JP JP2007232402A patent/JP2008024713A/en not_active Withdrawn
-
2008
- 2008-06-05 CY CY20081100591T patent/CY1109783T1/en unknown
-
2012
- 2012-03-21 JP JP2012062968A patent/JP2012126736A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2285923A1 (en) | 1998-10-08 |
NO325947B1 (en) | 2008-08-25 |
EP0971735A1 (en) | 2000-01-19 |
SI0971735T1 (en) | 2008-08-31 |
DK0971735T3 (en) | 2008-07-07 |
JP2012126736A (en) | 2012-07-05 |
DE69839261D1 (en) | 2008-04-30 |
WO1998043667A1 (en) | 1998-10-08 |
NZ500696A (en) | 2002-05-31 |
JP2008024713A (en) | 2008-02-07 |
US6277836B1 (en) | 2001-08-21 |
NO994778D0 (en) | 1999-09-30 |
IL132145A0 (en) | 2001-03-19 |
ES2303351T3 (en) | 2008-08-01 |
IL132145A (en) | 2005-11-20 |
NO994778L (en) | 1999-11-30 |
CY1109783T1 (en) | 2013-09-04 |
AR012304A1 (en) | 2000-10-18 |
EP0971735A4 (en) | 2004-02-25 |
DE69839261T2 (en) | 2009-03-26 |
EP0971735B1 (en) | 2008-03-19 |
JP2001524951A (en) | 2001-12-04 |
PT971735E (en) | 2008-06-02 |
CA2285923C (en) | 2013-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE389417T1 (en) | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY BOWEL DISEASE | |
ATE241977T1 (en) | USE OF ANTI-MICROTUBULAR AGENTS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE | |
DE69820997D1 (en) | COMPOSITIONS AND METHODS FOR TREATING THE INCREASED EYES PRINTOUT | |
DE60003250D1 (en) | Cleaning compositions and cleaning methods | |
DE69834256D1 (en) | METHOD AND COMPOSITION FOR TREATING DELAYED ALLERGIC REACTIONS AND INFLAMMATORY DISEASES | |
DE69519235D1 (en) | HEMORRHOID COMPOSITIONS AND METHOD FOR USE THEREOF | |
ATE477270T1 (en) | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING ANEMIA | |
ATE282591T1 (en) | THIOUREA COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFLAMMATORY DISEASES AND ATHEROSCLEROSIS | |
DE69836200D1 (en) | Implant material and process for its preparation | |
DE60042184D1 (en) | Method and composition for removing photoresist | |
DE60018635D1 (en) | Monofilament and process for its preparation | |
ATE288278T1 (en) | METHOD AND COMPOSITIONS FOR PEPTIDE SYNTHESIS | |
DE69714828D1 (en) | Waste treatment methods | |
DE69822873D1 (en) | COMPOSITIONS AND METHODS FOR WEIGHT REDUCTION | |
DE69719284D1 (en) | Cast article and process for its manufacture | |
ATE263777T1 (en) | COMPOSITIONS FOR TREATING INFLAMMATORY REACTIONS | |
ATE271598T1 (en) | DISINFECTANT COMPOSITIONS AND METHODS | |
DE69519577D1 (en) | PREDNISOLONMETASULFOBENZOATE COMPOSITION FOR TREATING INFLAMMATORY DISEASE OF THE COLON | |
DE69909355D1 (en) | Linked objects and methods of making such connected objects | |
DE69732470D1 (en) | Degradable monofilament and process for its preparation | |
ATE415163T1 (en) | METHODS AND COMPOSITIONS FOR TREATING EYE DISEASES | |
DE69924489D1 (en) | CEREAL BETA-GLUKANE COMPOSITIONS AND METHOD | |
DE69834578D1 (en) | METHOD FOR THE TREATMENT OF CEMENT TEMPERATURES | |
ATE222910T1 (en) | TRIPTOLIDE DERIVATIVES USEFUL FOR TREATING AUTOIMMUNE DISEASES | |
DE69919254D1 (en) | Water absorbent and process for its manufacture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0971735 Country of ref document: EP |